Another important point is that the minimal allele burden (variant allele frequency, VAF) required to define some neoplasms is not well delineated, and sometimes, the role of a lesion expressed at low VAF (for example JAK2 V617F at <2%) remains unclear in the setting of multiple concomitant mutations detected in the same patient. Here, JAK2 is linked to neoplasm.